Cargando…

DysPIA: A Novel Dysregulated Pathway Identification Analysis Method

Differential co-expression-based pathway analysis is still limited and not widely used. In most current methods, the pathways were considered as gene sets, but the gene regulation relationships were not considered, and the computational speed was slow. In this article, we proposed a novel Dysregulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Limei, Xie, Weixin, Li, Kongning, Wang, Zhenzhen, Li, Xia, Feng, Weixing, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287415/
https://www.ncbi.nlm.nih.gov/pubmed/34290733
http://dx.doi.org/10.3389/fgene.2021.647653
_version_ 1783723913574875136
author Wang, Limei
Xie, Weixin
Li, Kongning
Wang, Zhenzhen
Li, Xia
Feng, Weixing
Li, Jin
author_facet Wang, Limei
Xie, Weixin
Li, Kongning
Wang, Zhenzhen
Li, Xia
Feng, Weixing
Li, Jin
author_sort Wang, Limei
collection PubMed
description Differential co-expression-based pathway analysis is still limited and not widely used. In most current methods, the pathways were considered as gene sets, but the gene regulation relationships were not considered, and the computational speed was slow. In this article, we proposed a novel Dysregulated Pathway Identification Analysis (DysPIA) method to overcome these shortcomings. We adopted the idea of Correlation by Individual Level Product into analysis and performed a fast enrichment analysis. We constructed a combined gene-pair background which was much more sufficient than the background used in Edge Set Enrichment Analysis. In simulation study, DysPIA was able to identify the causal pathways with high AUC (0.9584 to 0.9896). In p53 mutation data, DysPIA obtained better performance than other methods. It obtained more potential dysregulated pathways that could be literature verified, and it ran much faster (∼1,700–8,000 times faster than other methods when 10,000 permutations). DysPIA was also applied to breast cancer relapse dataset and breast cancer subtype dataset. The results show that DysPIA is effective and has a great biological significance. R packages “DysPIA” and “DysPIAData” are constructed and freely available on R CRAN (https://cran.r-project.org/web/packages/DysPIA/index.html and https://cran.r-project.org/web/packages/DysPIAData/index.html), and on GitHub (https://github.com/lemonwang2020).
format Online
Article
Text
id pubmed-8287415
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82874152021-07-20 DysPIA: A Novel Dysregulated Pathway Identification Analysis Method Wang, Limei Xie, Weixin Li, Kongning Wang, Zhenzhen Li, Xia Feng, Weixing Li, Jin Front Genet Genetics Differential co-expression-based pathway analysis is still limited and not widely used. In most current methods, the pathways were considered as gene sets, but the gene regulation relationships were not considered, and the computational speed was slow. In this article, we proposed a novel Dysregulated Pathway Identification Analysis (DysPIA) method to overcome these shortcomings. We adopted the idea of Correlation by Individual Level Product into analysis and performed a fast enrichment analysis. We constructed a combined gene-pair background which was much more sufficient than the background used in Edge Set Enrichment Analysis. In simulation study, DysPIA was able to identify the causal pathways with high AUC (0.9584 to 0.9896). In p53 mutation data, DysPIA obtained better performance than other methods. It obtained more potential dysregulated pathways that could be literature verified, and it ran much faster (∼1,700–8,000 times faster than other methods when 10,000 permutations). DysPIA was also applied to breast cancer relapse dataset and breast cancer subtype dataset. The results show that DysPIA is effective and has a great biological significance. R packages “DysPIA” and “DysPIAData” are constructed and freely available on R CRAN (https://cran.r-project.org/web/packages/DysPIA/index.html and https://cran.r-project.org/web/packages/DysPIAData/index.html), and on GitHub (https://github.com/lemonwang2020). Frontiers Media S.A. 2021-07-05 /pmc/articles/PMC8287415/ /pubmed/34290733 http://dx.doi.org/10.3389/fgene.2021.647653 Text en Copyright © 2021 Wang, Xie, Li, Wang, Li, Feng and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Wang, Limei
Xie, Weixin
Li, Kongning
Wang, Zhenzhen
Li, Xia
Feng, Weixing
Li, Jin
DysPIA: A Novel Dysregulated Pathway Identification Analysis Method
title DysPIA: A Novel Dysregulated Pathway Identification Analysis Method
title_full DysPIA: A Novel Dysregulated Pathway Identification Analysis Method
title_fullStr DysPIA: A Novel Dysregulated Pathway Identification Analysis Method
title_full_unstemmed DysPIA: A Novel Dysregulated Pathway Identification Analysis Method
title_short DysPIA: A Novel Dysregulated Pathway Identification Analysis Method
title_sort dyspia: a novel dysregulated pathway identification analysis method
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287415/
https://www.ncbi.nlm.nih.gov/pubmed/34290733
http://dx.doi.org/10.3389/fgene.2021.647653
work_keys_str_mv AT wanglimei dyspiaanoveldysregulatedpathwayidentificationanalysismethod
AT xieweixin dyspiaanoveldysregulatedpathwayidentificationanalysismethod
AT likongning dyspiaanoveldysregulatedpathwayidentificationanalysismethod
AT wangzhenzhen dyspiaanoveldysregulatedpathwayidentificationanalysismethod
AT lixia dyspiaanoveldysregulatedpathwayidentificationanalysismethod
AT fengweixing dyspiaanoveldysregulatedpathwayidentificationanalysismethod
AT lijin dyspiaanoveldysregulatedpathwayidentificationanalysismethod